Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics
Acute coronary syndrome (ACS) refers to a spectrum of conditions characterized by a sudden decrease in blood flow to the heart. This includes unstable angina, the mildest form, as well as non-ST- and ST-segment elevation myocardial infarction. The primary cause of ACS is typically the rupture or ero...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Journal of Cardiovascular Development and Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2308-3425/12/5/188 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850257500273639424 |
|---|---|
| author | Gabriele Nieddu Marilena Formato Antonio Junior Lepedda |
| author_facet | Gabriele Nieddu Marilena Formato Antonio Junior Lepedda |
| author_sort | Gabriele Nieddu |
| collection | DOAJ |
| description | Acute coronary syndrome (ACS) refers to a spectrum of conditions characterized by a sudden decrease in blood flow to the heart. This includes unstable angina, the mildest form, as well as non-ST- and ST-segment elevation myocardial infarction. The primary cause of ACS is typically the rupture or erosion of an atherosclerotic plaque in a coronary artery, resulting in the formation of a blood clot that can, partially or completely, block the blood flow to the heart muscle. The ongoing discovery and comprehension of emerging biomarkers for atherosclerosis could enhance our capacity to predict future events, particularly when integrated alongside traditional risk factors in assessing overall risk profiles. With advancements in proteomic technologies, large-scale approaches have been increasingly instrumental in unraveling pathways implicated in atherosclerotic degeneration and identifying novel circulating markers, which may serve as early diagnostic indicators or targets for innovative therapies. Over recent decades, numerous matrices including plasma, urine, microparticles, lipoproteins, atherosclerotic plaque extracts and secretomes, as well as thrombi, have been examined to address these questions. Furthermore, proteomics has been applied to various experimental models of atherosclerosis to deepen our understanding of the mechanisms underlying atherogenesis. This review offers a critical overview of the past two decades of untargeted omics research focused on identifying circulating and tissue biomarkers relevant to ACS. |
| format | Article |
| id | doaj-art-97f74ae285644635b943573a113b97f8 |
| institution | OA Journals |
| issn | 2308-3425 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Cardiovascular Development and Disease |
| spelling | doaj-art-97f74ae285644635b943573a113b97f82025-08-20T01:56:24ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252025-05-0112518810.3390/jcdd12050188Deciphering Acute Coronary Syndromes Pathobiology Through ProteomicsGabriele Nieddu0Marilena Formato1Antonio Junior Lepedda2Department of Biomedical Sciences, University of Sassari, 07100 Sassari, ItalyDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, ItalyDepartment of Biomedical Sciences, University of Sassari, 07100 Sassari, ItalyAcute coronary syndrome (ACS) refers to a spectrum of conditions characterized by a sudden decrease in blood flow to the heart. This includes unstable angina, the mildest form, as well as non-ST- and ST-segment elevation myocardial infarction. The primary cause of ACS is typically the rupture or erosion of an atherosclerotic plaque in a coronary artery, resulting in the formation of a blood clot that can, partially or completely, block the blood flow to the heart muscle. The ongoing discovery and comprehension of emerging biomarkers for atherosclerosis could enhance our capacity to predict future events, particularly when integrated alongside traditional risk factors in assessing overall risk profiles. With advancements in proteomic technologies, large-scale approaches have been increasingly instrumental in unraveling pathways implicated in atherosclerotic degeneration and identifying novel circulating markers, which may serve as early diagnostic indicators or targets for innovative therapies. Over recent decades, numerous matrices including plasma, urine, microparticles, lipoproteins, atherosclerotic plaque extracts and secretomes, as well as thrombi, have been examined to address these questions. Furthermore, proteomics has been applied to various experimental models of atherosclerosis to deepen our understanding of the mechanisms underlying atherogenesis. This review offers a critical overview of the past two decades of untargeted omics research focused on identifying circulating and tissue biomarkers relevant to ACS.https://www.mdpi.com/2308-3425/12/5/188CVDproteomicsACS biomarkersplaque vulnerability |
| spellingShingle | Gabriele Nieddu Marilena Formato Antonio Junior Lepedda Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics Journal of Cardiovascular Development and Disease CVD proteomics ACS biomarkers plaque vulnerability |
| title | Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics |
| title_full | Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics |
| title_fullStr | Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics |
| title_full_unstemmed | Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics |
| title_short | Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics |
| title_sort | deciphering acute coronary syndromes pathobiology through proteomics |
| topic | CVD proteomics ACS biomarkers plaque vulnerability |
| url | https://www.mdpi.com/2308-3425/12/5/188 |
| work_keys_str_mv | AT gabrielenieddu decipheringacutecoronarysyndromespathobiologythroughproteomics AT marilenaformato decipheringacutecoronarysyndromespathobiologythroughproteomics AT antoniojuniorlepedda decipheringacutecoronarysyndromespathobiologythroughproteomics |